首页> 外文期刊>Micromachines >A 3D-Printed Millifluidic Platform Enabling Bacterial Preconcentration and DNA Purification for Molecular Detection of Pathogens in Blood
【24h】

A 3D-Printed Millifluidic Platform Enabling Bacterial Preconcentration and DNA Purification for Molecular Detection of Pathogens in Blood

机译:3D打印的微流控平台,可进行细菌预浓缩和DNA纯化,用于血液中病原体的分子检测

获取原文
获取外文期刊封面目录资料

摘要

Molecular detection of pathogens in clinical samples often requires pretreatment techniques, including immunomagnetic separation and magnetic silica-bead-based DNA purification to obtain the purified DNA of pathogens. These two techniques usually rely on handling small tubes containing a few millilitres of the sample and manual operation, implying that an automated system encompassing both techniques is needed for larger quantities of the samples. Here, we report a three-dimensional (3D)-printed millifluidic platform that enables bacterial preconcentration and genomic DNA (gDNA) purification for improving the molecular detection of target pathogens in blood samples. The device consists of two millichannels and one chamber, which can be used to preconcentrate pathogens bound to antibody-conjugated magnetic nanoparticles (Ab-MNPs) and subsequently extract gDNA using magnetic silica beads (MSBs) in a sequential manner. The platform was able to preconcentrate very low concentrations (1–1000 colony forming units (CFU)) of Escherichia coli O157:H7 and extract their genomic DNA in 10 mL of buffer and 10% blood within 30 min. The performance of the platform was verified by detecting as low as 1 CFU of E. coli O157:H7 in 10% blood using either polymerase chain reaction (PCR) with post gel electrophoresis or quantitative PCR. The results suggest that the 3D-printed millifluidic platform is highly useful for lowering the limitations on molecular detection in blood by preconcentrating the target pathogen and isolating its DNA in a large volume of the sample.
机译:临床样品中病原体的分子检测通常需要预处理技术,包括免疫磁分离和基于磁性硅珠的DNA纯化以获得纯化的病原体DNA。这两种技术通常依赖于处理包含几毫升样品的小试管和手动操作,这意味着对于大量样品,需要包含这两种技术的自动化系统。在这里,我们报告了三维(3D)打印的微流控平台,该平台可实现细菌预浓缩和基因组DNA(gDNA)纯化,以改善血液样本中目标病原体的分子检测。该设备由两个毫通道和一个腔室组成,可用于预浓缩与抗体结合的磁性纳米颗粒(Ab-MNPs)结合的病原体,随后使用磁性硅胶珠(MSB)依次提取gDNA。该平台能够预浓缩非常低浓度的大肠杆菌O157:H7(1-1000个菌落形成单位(CFU)),并在30分钟内在10 mL缓冲液和10%血液中提取其基因组DNA。使用聚合酶链反应(PCR)和后凝胶电泳或定量PCR,可在10%的血液中检测低至1 CFU的大肠杆菌O157:H7,从而验证了平台的性能。结果表明,通过预浓缩目标病原体并在大量样品中分离其DNA,3D打印的毫流体平台对于降低血液中分子检测的限制非常有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号